Cancer Epidemiology Biomarkers & Prevention, Vol 4, Issue 6 627-634, Copyright © 1995 by American Association for Cancer Research

ARTICLES

Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation

LA Mooney, RM Santella, L Covey, AM Jeffrey, W Bigbee, MC Randall, TB Cooper, R Ottman, WY Tsai and L Wazneh
Columbia University School of Public Health, New York, New York 10032, USA.

Serial samples from 40 heavy smokers ( > or = pack/day for > or = 1 year) enrolled in a smoking cessation program were assayed for cotinine, polycyclic aromatic hydrocarbon (PAH)-DNA, 4-aminobiphenyl-hemoglobin (4-ABP-Hb) adducts, and glycophorin A (GPA) mutations. Blood samples were taken while subjects were smoking, and 10 weeks and 8 and 14 months after quitting. Cotinine was used to assess compliance with the cessation protocol. A significant reduction in mean PAH-DNA and 4-ABP-Hb adducts was observed after cessation in all persons who were cotinine-verified quitters ( < or = 25 ng/ml) for > or = 8 months (P < 0.05). Neither the GPA N/phi nor the GPA N/N mutation Vf was significantly reduced after smoking cessation, but results are limited by the small number (n = 18) of heterozygous individuals studied. The substantial reduction (50-75%) in PAH-DNA and 4-ABP-Hb adduct levels after quitting indicates these carcinogen adducts are reflective of smoking. Passive exposure to smoke at home was significantly associated with PAH-DNA adducts in active smokers and in ex-smokers 10 weeks after quitting (P < 0.01). The estimated half-life of the PAH-DNA adducts in leukocytes is 9-13 weeks by inspection of the mean biomarker levels from baseline and 10 weeks sample and 23 (95% confidence interval, 10-36 weeks) using a linear regression model that adjusted for background.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				K.-M. Lee, D. Kang, M. L. Clapper, M. Ingelman-Sundberg, M. Ono-Kihara, C. Kiyohara, S. Min, Q. Lan, L. Le Marchand, P. Lin, et al. CYP1A1, GSTM1, and GSTT1 Polymorphisms, Smoking, and Lung Cancer Risk in a Pooled Analysis among Asian Populations Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1120 - 1126. [Abstract] [Full Text] [PDF]

				P. Vineis and F. Perera Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 547 - 567. [Abstract] [Full Text] [PDF]

				P. Vineis and F. Perera Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1954 - 1965. [Abstract] [Full Text] [PDF]

				K H Costenbader and E W Karlson Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus, November 1, 2006; 15(11): 737 - 745. [Abstract] [PDF]

				M M Freemer, T E King Jr, and L A Criswell Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus Ann Rheum Dis, May 1, 2006; 65(5): 581 - 584. [Abstract] [Full Text] [PDF]

				L. Airoldi, P. Vineis, A. Colombi, L. Olgiati, C. Dell'Osta, R. Fanelli, L. Manzi, F. Veglia, H. Autrup, A. Dunning, et al. 4-Aminobiphenyl-Hemoglobin Adducts and Risk of Smoking-Related Disease in Never Smokers and Former Smokers in the European Prospective Investigation into Cancer and Nutrition Prospective Study Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2118 - 2124. [Abstract] [Full Text] [PDF]

				L. A. Mooney, A. M. Madsen, D. Tang, M. A. Orjuela, W.-Y. Tsai, E. R. Garduno, and F. P. Perera Antioxidant Vitamin Supplementation Reduces Benzo(a)pyrene-DNA Adducts and Potential Cancer Risk in Female Smokers Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 237 - 242. [Abstract] [Full Text] [PDF]

				D. Palli, G. Masala, P. Vineis, S. Garte, C. Saieva, V. Krogh, S. Panico, R. Tumino, A. Munnia, E. Riboli, et al. Biomarkers of dietary intake of micronutrients modulate DNA adduct levels in healthy adults Carcinogenesis, April 1, 2003; 24(4): 739 - 746. [Abstract] [Full Text] [PDF]

				D. H. Phillips Smoking-related DNA and protein adducts in human tissues Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004. [Abstract] [Full Text] [PDF]

				P. G. Shields Tobacco Smoking, Harm Reduction, and Biomarkers J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444. [Abstract] [Full Text] [PDF]

				F. Perera, K. Hemminki, W. Jedrychowski, R. Whyatt, U. Campbell, Y. Hsu, R. Santella, R. Albertini, and J. P. O'Neill In Utero DNA Damage from Environmental Pollution Is Associated with Somatic Gene Mutation in Newborns Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1134 - 1137. [Abstract] [Full Text] [PDF]

				R. W. L. Godschalk, D. E. M. Feldker, P. J. A. Borm, E. F. M. Wouters, and F.-J. Van Schooten Body Mass Index Modulates Aromatic DNA Adduct Levels and Their Persistence in Smokers Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 790 - 793. [Abstract] [Full Text] [PDF]

				P. Georgiadis, J. Topinka, M. Stoikidou, S. Kaila, M. Gioka, K. Katsouyanni, R. Sram, H. Autrup, and S. A. Kyrtopoulos Biomarkers of genotoxicity of air pollution (the AULIS project): bulky DNA adducts in subjects with moderate to low exposures to airborne polycyclic aromatic hydrocarbons and their relationship to environmental tobacco smoke and other parameters Carcinogenesis, September 1, 2001; 22(9): 1447 - 1457. [Abstract] [Full Text] [PDF]

				D. Tang, D. H. Phillips, M. Stampfer, L. A. Mooney, Y. Hsu, S. Cho, W.-Y. Tsai, J. Ma, K. J. Cole, M. N. She, et al. Association between Carcinogen-DNA Adducts in White Blood Cells and Lung Cancer Risk in the Physicians Health Study Cancer Res., September 1, 2001; 61(18): 6708 - 6712. [Abstract] [Full Text] [PDF]

				L. A. Mooney, F. P. Perera, A. M. Van Bennekum, W. S. Blaner, J. Karkoszka, L. Covey, Y. Hsu, T. B. Cooper, and K. Frenkel Gender Differences in Autoantibodies to Oxidative DNA Base Damage in Cigarette Smokers Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 641 - 648. [Abstract] [Full Text] [PDF]

				F. P. Perera Molecular Epidemiology: On the Path to Prevention? J Natl Cancer Inst, April 19, 2000; 92(8): 602 - 612. [Abstract] [Full Text] [PDF]

				F. P. Perera and I.B. Weinstein Molecular epidemiology: recent advances and future directions Carcinogenesis, March 1, 2000; 21(3): 517 - 524. [Abstract] [Full Text] [PDF]

				J. K. Wiencke, S. W. Thurston, K. T. Kelsey, A. Varkonyi, J. C. Wain, E. J. Mark, and D. C. Christiani Early Age at Smoking Initiation and Tobacco Carcinogen DNA Damage in the Lung J Natl Cancer Inst, April 7, 1999; 91(7): 614 - 619. [Abstract] [Full Text] [PDF]

				S.-M. Hou, K. Yang, F. Nyberg, K. Hemminki, G. Pershagen, and B. Lambert Hprt mutant frequency and aromatic DNA adduct level in non-smoking and smoking lung cancer patients and population controls Carcinogenesis, March 1, 1999; 20(3): 437 - 444. [Abstract] [Full Text] [PDF]

				M. T. Zenzes, L. A. Puy, R. Bielecki, and T.E. Reed Detection of benzo[a]pyrene diol epoxide-DNA adducts in embryos from smoking couples: evidence for transmission by spermatozoa Mol. Hum. Reprod., February 1, 1999; 5(2): 125 - 131. [Abstract] [Full Text] [PDF]

				S. S. Hecht, S. G. Carmella, M. Chen, J. F. D. Koch, A. T. Miller, S. E. Murphy, J. A. Jensen, C. L. Zimmerman, and D. K. Hatsukami Quantitation of Urinary Metabolites of a Tobacco-specific Lung Carcinogen after Smoking Cessation Cancer Res., February 1, 1999; 59(3): 590 - 596. [Abstract] [Full Text] [PDF]